{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T11:49:56Z","timestamp":1793015396082,"version":"4.5.0"},"reference-count":51,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,2,25]],"date-time":"2022-02-25T00:00:00Z","timestamp":1645747200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurosci."],"abstract":"<jats:title>Graphical Abstract<\/jats:title><jats:p>[<jats:sup>18<\/jats:sup>F]2-fluoro-2-deoxy-D-glucose ([<jats:sup>18<\/jats:sup>F]FDG) PET imaging was performed in a mouse model of Alzheimer\u2019s disease to investigate the impact of donepezil on brain glucose metabolism.<\/jats:p>","DOI":"10.3389\/fnins.2022.835577","type":"journal-article","created":{"date-parts":[[2023,4,14]],"date-time":"2023-04-14T08:16:53Z","timestamp":1681460213000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["Impact of Donepezil on Brain Glucose Metabolism Assessed Using [18F]2-Fluoro-2-deoxy-D-Glucose Positron Emission Tomography Imaging in a Mouse Model of Alzheimer\u2019s Disease Induced by Intracerebroventricular Injection of Amyloid-Beta Peptide"],"prefix":"10.3389","volume":"16","author":[{"given":"Ga\u00eblle","family":"Hugon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Goutal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Sarazin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Bottlaender","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabien","family":"Caill\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marine","family":"Droguerre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathieu","family":"Charv\u00e9riat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Winkeler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Tournier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,2,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2014.00327","article-title":"A review of \u03b2-amyloid neuroimaging in Alzheimer\u2019s disease.","volume":"8","author":"Adlard","year":"2014","journal-title":"Front. Neurosci."},{"key":"B2","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1107\/S1600577516004045","article-title":"Amyloid-\u03b2 plaque deposition measured using propagation-based X-ray phase contrast CT imaging.","volume":"23","author":"Astolfo","year":"2016","journal-title":"J. Synchrotron Radiat."},{"key":"B3","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1007\/s00259-019-04516-z","article-title":"Repurposing radiotracers for myelin imaging: a study comparing 18F-florbetaben, 18F-florbetapir, 18F-flutemetamol,11C-MeDAS, and 11C-PiB.","volume":"47","author":"Auvity","year":"2020","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1093\/brain\/awv024","article-title":"Neuronal amyloid-\u03b2 accumulation within cholinergic basal forebrain in ageing and Alzheimer\u2019s disease.","volume":"138","author":"Baker-Nigh","year":"2015","journal-title":"Brain J. Neurol."},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2013.43","article-title":"Use of functional imaging across clinical phases in CNS drug development.","volume":"3","author":"Borsook","year":"2013","journal-title":"Transl. Psychiatry"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2019.00071","article-title":"18F-FDG-PET in mouse models of Alzheimer\u2019s disease.","volume":"6","author":"Bouter","year":"2019","journal-title":"Front. Med."},{"key":"B7","doi-asserted-by":"crossref","first-page":"954","DOI":"10.2967\/jnumed.115.167858","article-title":"Glial activation and glucose metabolism in a transgenic amyloid mouse model: a triple-tracer pet study.","volume":"57","author":"Brendel","year":"2016","journal-title":"J. Nucl. Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1097\/WNF.0000000000000324","article-title":"Donepezil\u2019s effects on brain functions of patients with alzheimer disease: a regional homogeneity study based on resting-state functional magnetic resonance imaging.","volume":"42","author":"Cheng","year":"2019","journal-title":"Clin. Neuropharmacol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.2967\/jnumed.109.065284","article-title":"Preclinical properties of 18F-AV-45: a pet agent for a\u03b2 plaques in the brain.","volume":"50","author":"Choi","year":"2009","journal-title":"J. Nucl. Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"6245","DOI":"10.1523\/JNEUROSCI.3672-12.2013","article-title":"A transgenic Alzheimer rat with plaques, tau pathology, behavioral impairment, oligomeric a\u03b2, and frank neuronal loss.","volume":"33","author":"Cohen","year":"2013","journal-title":"J. Neurosci."},{"key":"B11","article-title":"Alzheimer\u2019s disease drug development pipeline: 2021.","volume":"7","author":"Cummings","year":"2021","journal-title":"Alzheimers Dement."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1038\/npp.2012.25","article-title":"Palmitoylethanolamide protects against the amyloid-\u03b225-35-induced learning and memory impairment in mice, an experimental model of Alzheimer disease.","volume":"37","author":"D\u2019Agostino","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2016.00088","article-title":"Drug development in Alzheimer\u2019s disease: the contribution of PET and SPECT.","volume":"7","author":"Declercq","year":"2016","journal-title":"Front. Pharmacol."},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.4061\/2010\/604853","article-title":"In vivo imaging biomarkers in mouse models of Alzheimer\u2019s disease: are we lost in translation or breaking through?","volume":"2010","author":"Delatour","year":"2010","journal-title":"Int. J. Alzheimers Dis."},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2020.00563","article-title":"Efficacy of THN201, a combination of donepezil and mefloquine, to reverse neurocognitive deficits in Alzheimer\u2019s disease.","volume":"14","author":"Droguerre","year":"2020","journal-title":"Front. Neurosci."},{"key":"B16","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/0197-4580(92)90055-3","article-title":"The acute neurotoxicity and effects upon cholinergic axons of intracerebrally injected beta-amyloid in the rat brain.","volume":"13","author":"Emre","year":"1992","journal-title":"Neurobiol. Aging"},{"key":"B17","doi-asserted-by":"publisher","first-page":"S29","DOI":"10.1016\/j.jalz.2007.10.004","article-title":"Realizing the potential of positron emission tomography with 18F-fluorodeoxyglucose to improve the treatment of Alzheimer\u2019s disease.","volume":"4","author":"Foster","year":"2008","journal-title":"Alzheimers Dement."},{"key":"B18","first-page":"999","article-title":"Impact of animal handling on the results of 18F-FDG PET studies in mice.","volume":"47","author":"Fueger","year":"2006","journal-title":"J. Nucl. Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/s41583-018-0054-8","article-title":"Rodent models for Alzheimer disease.","volume":"19","author":"G\u00f6tz","year":"2018","journal-title":"Nat. Rev. Neurosci."},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0240228","article-title":"Comparative test-retest variability of outcome parameters derived from brain [18F]FDG PET studies in non-human primates.","volume":"15","author":"Goutal","year":"2020","journal-title":"PLoS One"},{"key":"B21","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA research framework: toward a biological definition of Alzheimer\u2019s disease.","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimers Dement."},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3390\/ijms221910637","article-title":"Donepezil regulates LPS and A\u03b2-stimulated neuroinflammation through MAPK\/NLRP3 inflammasome\/STAT3 signaling.","volume":"22","author":"Kim","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B23","first-page":"195","article-title":"Donepezil in Alzheimer\u2019s disease: an evidence-based review of its impact on clinical and economic outcomes.","volume":"1","author":"Knowles","year":"2006","journal-title":"Core Evid."},{"key":"B24","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1016\/j.nucmedbio.2010.05.001","article-title":"Optimization of automated radiosynthesis of [18F]AV-45: a new PET imaging agent for Alzheimer\u2019s disease.","volume":"37","author":"Liu","year":"2010","journal-title":"Nucl. Med. Biol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.cell.2019.09.001","article-title":"Alzheimer disease: an update on pathobiology and treatment strategies.","volume":"179","author":"Long","year":"2019","journal-title":"Cell"},{"key":"B26","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1016\/j.neuroimage.2003.08.020","article-title":"Assessment of microPET performance in analyzing the rat brain under different types of anesthesia: comparison between quantitative data obtained with microPET and ex vivo autoradiography.","volume":"20","author":"Matsumura","year":"2003","journal-title":"Neuroimage"},{"key":"B27","doi-asserted-by":"publisher","first-page":"513","DOI":"10.3233\/JAD-190546","article-title":"Efficacy and safety of cholinesterase inhibitors for mild cognitive impairment:a systematic review and meta-analysis.","volume":"71","author":"Matsunaga","year":"2019","journal-title":"J. Alzheimers Dis."},{"key":"B28","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/0006-8993(95)01032-7","article-title":"Amnesia induced in mice by centrally administered beta-amyloid peptides involves cholinergic dysfunction.","volume":"706","author":"Maurice","year":"1996","journal-title":"Brain Res."},{"key":"B29","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1038\/sj.bjp.0706927","article-title":"The anti-amnesic and neuroprotective effects of donepezil against amyloid \u03b225-35 peptide-induced toxicity in mice involve an interaction with the \u03c31 receptor.","volume":"149","author":"Meunier","year":"2006","journal-title":"Br. J. Pharmacol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1007\/s00259-005-1762-7","article-title":"Brain glucose metabolism in the early and specific diagnosis of Alzheimer\u2019s disease. FDG-PET studies in MCI and AD.","volume":"32","author":"Mosconi","year":"2005","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1212\/01.WNL.0000163856.13524.08","article-title":"Reduced hippocampal metabolism in MCI and AD: automated FDG-PET image analysis.","volume":"64","author":"Mosconi","year":"2005","journal-title":"Neurology"},{"key":"B32","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.ejphar.2012.12.023","article-title":"Characterization of cognitive deficits in a transgenic mouse model of Alzheimer\u2019s disease and effects of donepezil and memantine.","volume":"703","author":"Nagakura","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1016\/j.neurobiolaging.2011.09.026","article-title":"Increased regional cerebral glucose uptake in an APP\/PS1 model of Alzheimer\u2019s disease.","volume":"33","author":"Poisnel","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1016\/j.neurobiolaging.2012.12.027","article-title":"In vivo evaluation of amyloid deposition and brain glucose metabolism of 5XFAD mice using positron emission tomography.","volume":"34","author":"Rojas","year":"2013","journal-title":"Neurobiol. Aging"},{"key":"B35","first-page":"277","article-title":"Optimizing experimental protocols for quantitative behavioral imaging with 18F-FDG in rodents.","volume":"48","author":"Schiffer","year":"2007","journal-title":"J. Nucl. Med."},{"key":"B36","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1097\/NEN.0000000000000045","article-title":"Donepezil enhances Purkinje cell survival and alleviates motor dysfunction by inhibiting cholesterol synthesis in a murine model of Niemann Pick disease type C.","volume":"73","author":"Seo","year":"2014","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"B37","first-page":"11","article-title":"Evaluation of therapeutic response to donepezil by positron emission tomography.","volume":"57","author":"Shimada","year":"2011","journal-title":"Osaka City Med. J."},{"key":"B38","doi-asserted-by":"publisher","first-page":"274","DOI":"10.4062\/biomolther.2017.189","article-title":"The effects of donepezil, an acetylcholinesterase inhibitor, on impaired learning and memory in rodents.","volume":"26","author":"Shin","year":"2018","journal-title":"Biomol. Ther."},{"key":"B39","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/s1095-0397(99)00020-5","article-title":"Clinical value of neuroimaging in the diagnosis of dementia: sensitivity and specificity of regional cerebral metabolic and other parameters for early identification of Alzheimer\u2019s disease.","volume":"2","author":"Silverman","year":"1999","journal-title":"Clin. Positron Imaging"},{"key":"B40","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1007\/BF00173036","article-title":"Choice of reference region in the quantification of single-photon emission tomography in primary degenerative dementia.","volume":"21","author":"Talbot","year":"1994","journal-title":"Eur. J. Nucl. Med."},{"key":"B41","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.neuroscience.2020.10.015","article-title":"Challenges and perspectives of the hybridization of PET with functional MRI or ultrasound for neuroimaging.","volume":"474","author":"Tournier","year":"2020","journal-title":"Neuroscience"},{"key":"B42","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/S0969-8051(03)00124-0","article-title":"Evaluation of anesthesia effects on [18F]FDG uptake in mouse brain and heart using small animal PET.","volume":"31","author":"Toyama","year":"2004","journal-title":"Nucl. Med. Biol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1007\/s00259-009-1264-0","article-title":"EANM procedure guidelines for PET brain imaging using [18F]FDG, version 2.","volume":"36","author":"Varrone","year":"2009","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2020.173554","article-title":"Alzheimer\u2019s disease: recent treatment strategies.","volume":"887","author":"Vaz","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2020.00835","article-title":"Pharmaco-fUS for characterizing drugs for Alzheimer\u2019s disease - the Case of THN201, a drug combination of donepezil plus mefloquine.","volume":"14","author":"Vidal","year":"2020","journal-title":"Front. Neurosci."},{"key":"B46","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1093\/ijnp\/pyy027","article-title":"Cortico-amygdala-striatal activation by modafinil\/flecainide combination.","volume":"21","author":"Vodovar","year":"2018","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-015-0158-6","article-title":"In vivo molecular neuroimaging of glucose utilization and its association with fibrillar amyloid-\u03b2 load in aged APPPS1-21 mice.","volume":"7","author":"Waldron","year":"2015","journal-title":"Alzheimers Res. Ther."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.3233\/JAD-160760","article-title":"Longitudinal characterization of [18F]-FDG and [18F]-AV45 uptake in the double transgenic TASTPM mouse model.","volume":"55","author":"Waldron","year":"2017","journal-title":"J. Alzheimers Dis."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1002\/acn3.50848","article-title":"Donepezil increases resistance to induced seizures in a mouse model of Dravet syndrome.","volume":"6","author":"Wong","year":"2019","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1177\/1179573520907397","article-title":"Current and future treatments in alzheimer disease: an update.","volume":"12","author":"Yiannopoulou","year":"2020","journal-title":"J. Cent. Nerv. Syst. Dis."},{"key":"B51","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.ajpath.2011.03.021","article-title":"Time-course and regional analyses of the physiopathological changes induced after cerebral injection of an amyloid \u03b2 fragment in rats.","volume":"179","author":"Zussy","year":"2011","journal-title":"Am. J. Pathol."}],"container-title":["Frontiers in Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2022.835577\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,14]],"date-time":"2023-04-14T08:17:00Z","timestamp":1681460220000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2022.835577\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,25]]},"references-count":51,"alternative-id":["10.3389\/fnins.2022.835577"],"URL":"https:\/\/doi.org\/10.3389\/fnins.2022.835577","relation":{},"ISSN":["1662-453X"],"issn-type":[{"value":"1662-453X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,25]]},"article-number":"835577"}}